ReviewJournal of gastrointestinal oncology2025

Safety and efficacy of pemigatinib in patients with cholangiocarcinoma: a systematic review.

Warda Rasool et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.